Heard at HLTH 2025: Healthcare Executives Highlight AI, ROI, and Fertility Tech. (Video)
They shared new developments, their views on AI, and what they're doing to disrupt the status quo in healthcare.
They shared new developments, their views on AI, and what they're doing to disrupt the status quo in healthcare.
Ideas floated by the Trump Administration and Democrats in Congress aim to expand access to fertility treatment as an essential health benefit. But an influx of patients could collide with an already-brittle system of 430,000 annual cycles, 5,000 embryologists, and long-overdue lab upgrades.
Alan Murray on improving access for medical transportation.
Heranova Lifesciences recently launched a noninvasive blood test to diagnose endometriosis. The standard diagnostic method is laparoscopy, which requires anesthesia, followed by histological confirmation. With its blood test, Heranova seeks to replace the diagnostic function of laparoscopy, thus reserving surgical intervention only for therapeutic purposes.
The women’s health market offers enormous potential for investment and innovation. While challenges related to systemic inequalities remain, progress in venture capital funding is encouraging. Likewise, the overall increase in patent filings related to breast cancer, endometriosis, and other conditions appears to reflect a growing interest in women’s health.
Cofertility raised $7.25 million in Series A funds, taking its total funding to date to $16 million. The startup is making egg freezing more accessible by tying it to egg donation — it offers one program in which women can pay to freeze their eggs and store them all for their own later use, and another one that allows women to freeze their eggs for free when they give half to a family who can’t otherwise conceive.
Through Evvy's vaginal microbiome test, consumers can now receive insights on fertility. The vaginal microbiome is often overlooked when it comes to fertility, according to Priyanka Jain, CEO and co-founder of Evvy.
President Donald Trump recently announced an executive order on IVF. But it doesn't actually do much yet. Rather, it's asking for a list of recommendations to protect IVF access.
Future Family launched a nationwide IVF insurance product on Wednesday. If families don't achieve a live birth after two cycles of IVF, they can get their money back.
Carrot Fertility has partnered with Priority Health to offer two design solutions for fully-funded and self-funded employer groups. These solutions include support for fertility treatment, pregnancy, postpartum care, gestational surrogacy, adoption, menopause and low testosterone.
Aetna will begin covering intrauterine insemination. It is the first major insurer to update this coverage policy nationwide, the payer claimed.
Gameto's $33 million Series B funding round was led by Two Sigma Ventures and RA Capital. The funding will help with the clinical development of its in vitro maturation product called Fertilo.
Providers have an ethical imperative to facilitate a truly informed choice for parents and donors, which means educating them about the facts around anonymous donation, the potential needs of their donor-conceived child, and the importance of choosing programs that dedicate time and effort toward obtaining updated medical information.
Ovia Health unveiled a new fertility and family-building benefit for employers and health plans that includes financial support, care navigation services and one-on-one concierge support.
A new startup named Zuri Fertility recently launched. Its platform provides resources for patients who are trying to conceive — including telehealth, at-home testing, prescriptions, mental health services, education and care coordination.